HighTower Advisors’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Buy
563,741
+1,371
+0.2% +$2K ﹤0.01% 2448
2026
Q1
$815K Sell
562,370
-1,936
-0.3% -$3.07K ﹤0.01% 2340
2025
Q4
$779K Sell
564,306
-12,763
-2% -$26.7K ﹤0.01% 2297
2025
Q3
$1.58M Buy
577,069
+417,087
+261% +$1.48M ﹤0.01% 1780
2025
Q2
$558K Buy
159,982
+4,000
+3% +$15.8K ﹤0.01% 2426
2025
Q1
$574K Sell
155,982
-88,900
-36% -$325K ﹤0.01% 2346
2024
Q4
$394K Sell
244,882
-1,100
-0.4% -$1.14K ﹤0.01% 2668
2024
Q3
$187K Buy
245,982
+87,816
+56% +$115K ﹤0.01% 3159
2024
Q2
$285K Hold
158,166
﹤0.01% 2755
2024
Q1
$753K Sell
158,166
-25,000
-14% -$87.9K ﹤0.01% 1987
2023
Q4
$531K Buy
183,166
+26,000
+17% +$41K ﹤0.01% 2277
2023
Q3
$212K Buy
157,166
+3,537
+2% +$6.2K ﹤0.01% 2869
2023
Q2
$330K Hold
153,629
﹤0.01% 2505
2023
Q1
$446K Hold
153,629
﹤0.01% 2191
2022
Q4
$1.05M Hold
153,629
﹤0.01% 1642
2022
Q3
$489K Buy
153,629
+56,700
+58% +$206K ﹤0.01% 2048
2022
Q2
$312K Hold
96,929
﹤0.01% 2331
2022
Q1
$294K Sell
96,929
-20
-0% -$68 ﹤0.01% 2541
2021
Q4
$432K Buy
96,949
+20
+0% +$98 ﹤0.01% 2247
2021
Q3
$635K Buy
96,929
+22,675
+31% +$217K ﹤0.01% 1917
2021
Q2
$1.19M Hold
74,254
﹤0.01% 1534
2021
Q1
$919K Hold
74,254
﹤0.01% 1619
2020
Q4
$825K Sell
74,254
-68,000
-48% -$511K ﹤0.01% 1365
2020
Q3
$691K Buy
+142,254
New +$540K ﹤0.01% 1403

Other funds holding STIM

HighTower Advisors's STIM Position: Q2 2026 in Review

HighTower Advisors increased its Neuronetics (STIM) stake by 0.24% in Q2 2026, buying an estimated $2K and bringing the position to 563,741 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

HighTower Advisors first reported a position in STIM in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.58M in Q3 2025. 23 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • HighTower Advisors held 563,741 shares of Neuronetics worth $733K as of Q2 2026.
  • HighTower Advisors bought 1,371 Neuronetics shares in Q2 2026, an estimated $2K.
  • Neuronetics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2448 holding.
  • HighTower Advisors first reported a position in Neuronetics in Q3 2020 and has held it in 24 quarters since.
  • HighTower Advisors's Neuronetics position peaked at $1.58M in Q3 2025.
  • 23 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.